Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest news from Datamonitor

March 31, 2008
Sales and Marketing

The impact of the US presidential race on healthcare IT The three leaders in the race for the US presidency; …

News

The role of audit in marketing excellence

March 28, 2008
Sales and Marketing audit, excellence, marketing

The goal for any business leader, whether they run a company, business unit or brand, should always be 100% alignment …

Feature

Gardasil licence extension gets priority FDA review

March 28, 2008
Sales and Marketing

Merck has received priority review status from the FDA for its application to extend the licence of its cervical cancer …

News

Accomplia gains limited NICE approval

March 28, 2008
Sales and Marketing

Sanofi-Aventis' weight-loss pill Acomplia has been approved for prescription on the NHS, but only for patients who fail to respond …

News

Merck’s hepatitis B vaccine trial on hold

March 28, 2008
Sales and Marketing

US regulators have placed a 'clinical hold' on one of the trials for Merck's hepatitis B vaccine Heplisav, raising questions …

News

Boehringer Ingelheim’s Pradaxa approved in Europe

March 28, 2008
Sales and Marketing

European regulators have approved Boehringer Ingelheim's novel anti-clotting pill Pradaxa, paving the way it to be launched in the coming …

News

Pharming’s orphan drug receives second setback in Europe

March 26, 2008
Sales and Marketing HAE, Pharming

Dutch biotech company Pharming has suffered a blow, after its lead product Rhucin was rejected by European regulators for a …

News

NHS Trusts to promote their services to the public

March 25, 2008
Medical Communications

All patients needing routine hospital care will soon be able to choose from any approved NHS trust in the country. …

News

Latest news from Datamonitor

March 25, 2008
Sales and Marketing em

Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets …

News

Early access to experimental drugs for terminally ill

March 25, 2008
Sales and Marketing

Terminally ill cancer patients are to get early access to developmental drugs in a bid to halve the time it …

News

GSK consolidates Cervarix PR ahead of crucial vaccine decision

March 25, 2008
Medical Communications

GlaxoSmithKline has reorganised the PR support for its cervical cancer vaccine Cervarix, choosing just one agency to handle the UK …

News

Latest news from Datamonitor

March 20, 2008
Sales and Marketing

With pharmaceutical companies struggling to maintain pipelines and portfolios with products developed in-house, organizations are increasingly turning to licensing to …

News

Onwards and upwards

March 20, 2008
Business Services career, planning, recruitment

In an era of elusive blockbusters, job cuts and growing insecurity in the pharma industry, the skills you need to …

Feature

AZ and Silence to collaborate on gene technology

March 20, 2008
Research and Development

AstraZeneca has signed a deal with UK biotech firm Silence Therapeutics to develop a range of novel approaches for the …

News

Nexium and Seroquel face US generic fight

March 20, 2008
Sales and Marketing

AstraZeneca is to face a crucial court battle over one of its biggest brands, Seroquel. Generics companies Teva and Sandoz …

News

Manchester selected for translational medicine centre

March 19, 2008
Research and Development

A new Biomedical Research Centre of excellence is to be created in Manchester to help the UK bridge the gap …

News

Side-effect caution to delay Tyverb

March 19, 2008
Research and Development

GlaxoSmithKline has informed regulators in the US and Europe that a small number of patients taking its new breast cancer …

News

Industry doubts government commitment to innovation

March 19, 2008
Sales and Marketing

The government has unveiled high plans to make the UK a world leader in innovation, but the pharmaceutical industry remains …

News

Practice based commissioning and NICE workshops launched

March 14, 2008

The impact of practice-based commissioning (PBC) on how NICE guidance is implemented will be explored in a series of regional …

News

Celgene buys up Pharmion

March 14, 2008
Sales and Marketing

Specialist biopharma company Celgene has bought Pharmion for $2.9 billion in a bid to become a global leader in haematology …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025